Improved postoperative pain control in pediatric adenotonsillectomy with dextromethorphan

Area of Science:

• Pediatric Anesthesiology
• Pain Management
• Pharmacology

Background:

• Adenotonsillectomy is a common pediatric surgical procedure.
• Postoperative pain management is crucial for recovery.
• Opioid analgesics are frequently used but carry risks.

Purpose of the Study:

• To evaluate the efficacy of dextromethorphan in reducing postoperative morphine requirements in children undergoing adenotonsillectomy.
• To assess the safety profile of pre-operative dextromethorphan administration.

Main Methods:

• Prospective, randomized, double-blinded, placebo-controlled study.
• 40 children (ages 3-13) received either dextromethorphan (1 mg/kg) or placebo 30 minutes before surgery.
• Intravenous morphine requirement within 6 hours post-surgery was the primary outcome measure.

Main Results:

• Fewer patients in the dextromethorphan group required morphine post-surgery (P=.03).
• The mean morphine dose was significantly lower in the dextromethorphan group (P=.02).
• No drug-related adverse events were reported.

Conclusions:

• Dextromethorphan is a safe, non-narcotic option for reducing postoperative opioid needs.
• Pre-operative administration of dextromethorphan is effective in managing pain after pediatric adenotonsillectomy.
• Routine use of dextromethorphan is recommended for this patient population.